210 related articles for article (PubMed ID: 17786274)
21. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
[TBL] [Abstract][Full Text] [Related]
23. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
24. The Wiskott-Aldrich syndrome.
Ochs HD
Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
[TBL] [Abstract][Full Text] [Related]
25. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
[TBL] [Abstract][Full Text] [Related]
26. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
Olivier A; Jeanson-Leh L; Bouma G; Compagno D; Blondeau J; Seye K; Charrier S; Burns S; Thrasher AJ; Danos O; Vainchenker W; Galy A
Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
[TBL] [Abstract][Full Text] [Related]
27. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
28. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
[TBL] [Abstract][Full Text] [Related]
29. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the Wiskott-Aldrich syndrome protein and other actin regulatory adaptors in T cell activation.
Badour K; Zhang J; Siminovitch KA
Semin Immunol; 2004 Dec; 16(6):395-407. PubMed ID: 15541654
[TBL] [Abstract][Full Text] [Related]
31. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton.
Takenawa T; Suetsugu S
Nat Rev Mol Cell Biol; 2007 Jan; 8(1):37-48. PubMed ID: 17183359
[TBL] [Abstract][Full Text] [Related]
32. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
33. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection.
Garmendia J; Carlier MF; Egile C; Didry D; Frankel G
Cell Microbiol; 2006 Sep; 8(9):1444-55. PubMed ID: 16922863
[TBL] [Abstract][Full Text] [Related]
34. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
35. Wiskott-Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations.
El-Hakeh J; Rosenzweig S; Oleastro M; Basack N; Berozdnik L; Molina F; Rivas EM; Zelazko M; Danielian S
Hum Mutat; 2002 Feb; 19(2):186-7. PubMed ID: 11793485
[TBL] [Abstract][Full Text] [Related]
36. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
[TBL] [Abstract][Full Text] [Related]
37. A novel termination codon mutation of the WAS gene in a Thai family with Wiskott-Aldrich syndrome.
Chatchatee P; Srichomthong C; Chewatavorn A; Shotelersuk V
Int J Mol Med; 2003 Dec; 12(6):939-41. PubMed ID: 14612970
[TBL] [Abstract][Full Text] [Related]
38. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.
Devriendt K; Kim AS; Mathijs G; Frints SG; Schwartz M; Van Den Oord JJ; Verhoef GE; Boogaerts MA; Fryns JP; You D; Rosen MK; Vandenberghe P
Nat Genet; 2001 Mar; 27(3):313-7. PubMed ID: 11242115
[TBL] [Abstract][Full Text] [Related]
39. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
Andreu N; Matamoros N; Escudero A; Fillat C
Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
[TBL] [Abstract][Full Text] [Related]
40. The polarization defect of Wiskott-Aldrich syndrome macrophages is linked to dislocalization of the Arp2/3 complex.
Linder S; Higgs H; Hüfner K; Schwarz K; Pannicke U; Aepfelbacher M
J Immunol; 2000 Jul; 165(1):221-5. PubMed ID: 10861055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
